The Zacks Analyst Blog Highlights Alibaba, Pfizer, MercadoLibre and SIFCO

Zacks

02-25

For Immediate Release Chicago, IL – February 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ...

網頁鏈接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2514719093"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514719093\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2514719093?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-25 18:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514719093","market":"us","top_or_hot":-1,"title":"The Zacks Analyst Blog Highlights Alibaba, Pfizer, MercadoLibre and SIFCO","media":"Zacks","content":"<html><body><div>\n<p>For Immediate Release\nChicago, IL – February 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ...</p>\n<a href=\"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-alibaba-105300093.html\">網頁鏈接</a>\n</div>\n</body></html>","source":"yahoofinance_sg","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>The Zacks Analyst Blog Highlights Alibaba, Pfizer, MercadoLibre and SIFCO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Zacks Analyst Blog Highlights Alibaba, Pfizer, MercadoLibre and SIFCO\n</h2>\n<h4 class=\"meta\">\n</h4><p class=\"head\">\n<strong class=\"h-name small\">Zacks</strong><span class=\"h-time small\">2025-02-25 18:53</span>\n</p>\n</header>\n<article>\n<div>\n<p>For Immediate Release\nChicago, IL – February 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ...</p>\n<a href=\"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-alibaba-105300093.html\">網頁鏈接</a>\n</div>\n<div class=\"bt-text\">\n<p> 來源：<a href=\"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-alibaba-105300093.html\">Zacks</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0880133367.SGD","symbol_name":"UBS (LUX) EQUITY FUND CHINA OPPORTUNITY USD \"P\" (SGD) ACC","start_time":0,"source_url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-alibaba-105300093.html","article_id":"2514719093","we_media_id":null,"thumbnails":[],"rights":{"source":"yahoofinance_sg","url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-alibaba-105300093.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2514719093","pubTimestamp":1740480780,"columns":[],"sourceInfo":{"source_id":"yahoofinance_sg","name":"Yahoo Finance"},"weMediaInfo":null,"summary":"Chicago, IL – February 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alibaba Group Holding Ltd. BABA, Pfizer Inc. PFE, MercadoLibre, Inc. MELI and SIFCO Industries, Inc. SIF.Top Research Reports for Alibaba, Pfizer and MercadoLibre","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0880133367.SGD":"UBS (LUX) EQUITY FUND CHINA OPPORTUNITY USD \"P\" (SGD) ACC","BK4213":"石油与天然气的勘探与生产","LU0823411888.USD":"法巴消费创新基金 Cap","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","SIF":"SIFCO Industries Inc","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1868838027.USD":"CT (LUX) I GLOBAL EMERGING MARKET EQUITIES \"8\" (USD) ACC","09988":"阿里巴巴-W","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU0256331488.USD":"SCHRODER ISF GLOBAL ENERGY \"A\" ACC","SGXZ51526630.SGD":"大华环球创新基金A Acc SGD","LU2279701549.SGD":"JPMorgan Funds - Emerging Markets Sustainable Equity A (acc) SGD","BK4558":"双十一","BK4587":"ChatGPT概念","BK4575":"芯片概念","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU1105468828.SGD":"Allianz Total Return Asian Equity AM DIS H2-SGD","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","BK4535":"淡马锡持仓","MELI":"MercadoLibre","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU1048596156.SGD":"Blackrock Asian Growth Leaders A2 SGD-H","LU1152091754.HKD":"UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) \"PM\" (HKD) INC","LU2360107168.USD":"BGF NEXT GENERATION TECHNOLOGY \"A4\" (USD) INC","BK4579":"人工智能","BK4568":"美国抗疫概念","BK4526":"热门中概股","BK4588":"碎股","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","BK6130":"综合零售","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","BK4122":"互联网与直销零售","LU1152091168.USD":"UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) \"PM\" INC","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","BK4607":"DeepSeek概念股","MRO":"马拉松石油","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","LU0651946864.USD":"贝莱德新兴市场股票收益A2","LU0072913022.USD":"UBS (LUX) EQUITY FUND -  GREATER CHINA \"P\" (USD) ACC","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","IE00BFMHRM44.USD":"NEUBERGER BERMAN GLOBAL EQUITY MEGATRENDS \"A\" (USD) ACC","PFE":"辉瑞","SG9999001176.USD":"United Global Healthcare Acc USD","BABA":"阿里巴巴","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","HBBD.SI":"Alibaba HK SDR 5to1","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD"},"translate_title":"Zacks分析师博客重点介绍了阿里巴巴-SW、辉瑞、MercadoLibre和SIFCO","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BABA":1,"SIF":1,"PFE":1,"MRO":1,"MELI":1,"HBBD.SI":0.9,"09988":0.6},"content_text":"For Immediate Release\nChicago, IL – February 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alibaba Group Holding Ltd. BABA, Pfizer Inc. PFE, MercadoLibre, Inc. MELI and SIFCO Industries, Inc. SIF.\nHere are highlights from Monday’s Analyst Blog:\nTop Research Reports for Alibaba, Pfizer and MercadoLibre\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Ltd., Pfizer Inc. and MercadoLibre, Inc., as well as a micro-cap stock SIFCO Industries, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Ahead of Wall StreetThe daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.You can read today's AWS here >>> Pre-Markets Bouncing Back from Dismal FridayToday's Featured Research ReportsAlibaba’s shares have outperformed the Zacks Internet - Commerce industry over the past year (+66.5% vs. +32.1%). The company’s Q3 fiscal 2025 results benefited from the monetization of Taobao and Tmall Group, cloud businesses and AI-integrated products. BABA is riding on strong momentum in its international commerce retail business, driven by strength in AliExpress’ Choice.Growing international commerce wholesale business, thanks to strength in cross-border-related value-added services, is a tailwind. Expanding China's wholesale commerce business is a positive. Robust local consumer services and Cainiao logistics services are further driving top-line growth.However, non-GAAP earnings of $2.93 per ADS fell short of estimates, suggesting a complex growth narrative. Current market valuations, with the stock trading at multi-year highs, suggest limited immediate upside potential.(You can read the full research report on Alibaba here >>>)Shares of Pfizer have declined -0.2% over the past year against the Zacks Large Cap Pharmaceuticals industry’s decline of -1.4%. The company beat fourth-quarter estimates for both earnings and sales. Pfizer’s non-COVID operational revenue growth improved in 2024, driven by its key in-line products like Vyndaqel, Padcev and Eliquis, new launches and newly acquired products from Seagen.Huge profits from its COVID products strengthened its cash position. Seagen’s acquisition has strengthened its position in the oncology market. Continued growth in non-COVID sales and significant cost-reduction measures should drive profit growth.However, with the end of the pandemic, sales of Pfizer’s COVID products have declined steeply. Pfizer also expects a significant impact from the loss of patent exclusivity in the 2026-2030 period, as several of its key products face patent expirations.(You can read the full research report on Pfizer here >>>)MercadoLibre’s shares have gained +31% over the past year against the Zacks Internet - Commerce industry’s gain of +32.1%. The company reported impressive fourth-quarter 2024 results, wherein both revenues and earnings improved on a year-over-year basis. Accelerating commerce and fintech revenues contributed well. Rising gross merchandise volume (GMV) was a major positive.Increasing total payments volume (TPV), courtesy of the robust Mercado Pago, aided the company’s top-line growth. Strong momentum across Brazil and Mexico was a tailwind. Increasing demand for the company's advertising services was another positive. Growing momentum across the MELI+ loyalty program and its expanding credit card offerings are acting as tailwinds.However, rising e-commerce competition from players like Amazon and Rakuten remains a concern. Weakening macro conditions in Argentina is a headwind.(You can read the full research report on MercadoLibre here >>>)Shares of SIFCO have gained +12.2% over the past year against the Zacks Aerospace - Defense Equipment industry’s gain of +23.7%. This microcap company with market capitalization of $19.98 million achieved a 20.5% revenue increase in fiscal 2024, reaching $79.6 million from $66.1 million in fiscal 2023, driven by strong demand in aerospace and energy.Profitability improved, with EBITDA loss narrowing to $0.7 million from $4.4 million, while adjusted EBITDA turned positive at $0.8 million. A $114.4 million backlog supports future growth, especially as demand for defense and maintenance, repair and overhaul (MRO) rises.However, interest expenses surged 208.9% to $3.1 million, and operating losses persist at $5.2 million despite revenue gains. Margins remain thin at 7.5%, constrained by supply chain disruptions and labor costs. Intense competition, limited innovation in emerging aerospace technologies and cyclical industry exposure pose further risks. Financial flexibility remains a concern, with cash flow challenges.(You can read the full research report on SIFCO here >>>)\nWhy Haven't You Looked at Zacks' Top Stocks?\nSince 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.\nToday you can access their live picks without cost or obligation.\nSee Stocks Free >>\nZacks Investment Research\n800-767-3771 ext. 9339\nsupport@zacks.com\nhttps://www.zacks.com\nPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nPfizer Inc. (PFE) : Free Stock Analysis Report\nMercadoLibre, Inc. (MELI) : Free Stock Analysis Report\nAlibaba Group Holding Limited (BABA) : Free Stock Analysis Report\nSIFCO Industries, Inc. (SIF): Free Stock Analysis Report\nThis article originally published on Zacks Investment Research (zacks.com).\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0}}}